RxDoctor Payments Data

Kevin O'Malley

Orthopaedic Surgery · Washington, DCNPI 1770901670

Payments from drug & device makers

What this record shows

Supreme Orthopedic Systems, LLC accounts for 64.4% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2020 at $1,069 and has fallen 90.4% since, to $102 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in DC, where the typical reported total is $4,260.

$1,938in general payments, 2019–2025

Across 18 payments — averaging $107.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supreme Orthopedic Systems, LLC$1K
  • Stryker$512
  • Endo Pharmaceuticals Inc.$64
  • Acumed LLC$46
  • Endo USA, Inc.$37
  • Solventum Corporation$32

What the payments were for

  • Food & beverage$86945%
  • Education$1,06955%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,938 in reported general payments places this provider in the 30th percentile of 46 orthopaedic surgery providers in District of Columbia.

See all orthopaedic surgery providers in District of Columbia

Medicare billing

Part B allowed, 2024
$250,474
Medicare patients
578
Services billed
2,028

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium17$745
Gabapentin13$259
Celecoxib14$200
Meloxicam57$136
Tramadol Hcl17$27

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →